Redcare Pharmacy Defies Market Pessimism with Robust Quarterly Performance

Despite facing significant headwinds in its stock performance this year, Redcare Pharmacy has delivered a powerful demonstration of its underlying operational strength in the third quarter. The online pharmacy’s latest financial report reveals a company experiencing explosive growth in its core prescription business, even as its share price languishes near annual lows.

While Redcare’s equity value has declined by more than 45% since the beginning of the year and currently trades close to its 52-week low, the company’s financial metrics tell a different story. Total quarterly revenue advanced by 25% to reach €719 million. The company maintained solid profitability, with adjusted EBITDA coming in at €17.1 million, representing a 2.4% margin. This Read more...